KANK1 and myeloproliferative neoplasm: A t(5;9) translocation resulting in a chimeric fusion protein of the platelet-derived growth factor receptor β gene (PDGFRB) and KANK1 was detected in a patient with a myeloproliferative neoplasm (MPN) characterised with severe thrombocythemia [17].